Once non-small-cell lung ... that attack cancer cells in specific ways based on gene differences. Your doctor will do a test to look for: They slow down how fast tumors grow and spread.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Figure 1: Treatment with Bria-OTS monotherapy resulted in 100% resolution of tumor in the lung of the metastatic breast cancer (MBC) patient following 2 months of therapy and confirmed at 4 months ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Lung cancer is the leading cause of cancer-related death in the U.S. This makes lung cancer screening important.

Lung metastasis in metastatic breast cancer patient fully resolved at 2 months, confirmed at 4 months post-Bria-OTS treatment. Patient showed stable disease elsewhere after lowest dose of Bria-OTS ...